In a report released today, Les Sulewski from Truist Financial maintained a Buy rating on biote (BTMD – Research Report). The company’s shares ...
Truist upgraded pain therapy developer Pacira BioSciences (NASDAQ:PCRX) to Hold from Sell on Thursday, noting that the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback